Literature DB >> 6191861

Diversity of immunological phenotypes of lymphoblastic lymphoma.

J Cossman, T M Chused, R I Fisher, I Magrath, F Bollum, E S Jaffe.   

Abstract

Eleven cases of lymphoblastic malignancy, presenting as lymphoma, were investigated for immunological and differentiation markers prior to the onset of therapy. Biopsy specimens exhibited the typical morphological features of lymphoblastic lymphoma (convoluted T-cell lymphoma). Intranuclear terminal deoxynucleotidyl transferase was detected in the neoplastic cells from each case by indirect antibody staining of cytocentrifuge preparations. Eight cases were T-cell type as evidenced by unsensitized sheep erythrocyte rosette formation and staining with the monoclonal antibody OKT11. Three T-cell cases were OKT4 positive, two were OKT8 positive, and none were positive with both OKT4 and OKT8. Three cases failed to react with any monoclonal antibodies specific for T-cells and did not form unsensitized sheep erythrocyte rosettes or stain for surface immunoglobulin. However, these three cases were Ia positive and J5 (common acute lymphoblastic leukemia antigen) positive. Cells from two of these erythrocyte rosette-negative, Ia-positive, common acute lymphoblastic leukemia-positive cases contained intracytoplasmic mu heavy chains and were therefore of pre-B-cell phenotype. These cases were histologically indistinguishable from the T-cell cases. However, clinically, they were distinguished by the absence of mediastinal masses and by a clinical presentation as isolated lytic lesions of bone in two of the three. OKT9 and OKT10 stained neoplastic cells from T-cell, as well as pre-B-lymphoblastic, lymphoma. Although morphologically homogeneous, lymphoblastic lymphomas are comprised of an immunologically diverse group of neoplasms which include cells of "common" and "mature" thymocyte, non-T, non-B, and pre-B phenotypes and are closely related to the cells of acute lymphoblastic leukemia. In addition, intratumor heterogeneity was observed in most instances and may reflect growth or differentiation differences between subpopulations of individual neoplastic clones.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6191861

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Unusual lymphoblastic leukemia/lymphoma in Eastern Iran.

Authors:  Mehrbod Karimi; P Eshghi
Journal:  Indian J Pediatr       Date:  2006-07       Impact factor: 1.967

2.  Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas.

Authors:  L M Weiss; G S Crabtree; R V Rouse; R A Warnke
Journal:  Am J Pathol       Date:  1985-02       Impact factor: 4.307

3.  Childhood non-Hodgkin lymphomas in the United Kingdom: findings from the UK Children's Cancer Study Group.

Authors:  D Wright; P McKeever; R Carter
Journal:  J Clin Pathol       Date:  1997-02       Impact factor: 3.411

4.  Inferior outcomes of stage III T lymphoblastic lymphoma relative to stage IV lymphoma and T-acute lymphoblastic leukemia: long-term comparison of outcomes in the JACLS NHL T-98 and ALL T-97 protocols.

Authors:  Ryoji Kobayashi; Tetsuya Takimoto; Atsuko Nakazawa; Naoto Fujita; Ayumi Akazai; Kazumi Yamato; Makoto Yazaki; Takao Deguchi; Yoshiko Hashii; Koji Kato; Naoki Hatakeyama; Keizo Horibe; Hiroki Hori; Megumi Oda
Journal:  Int J Hematol       Date:  2014-05-07       Impact factor: 2.490

5.  Two entities of precursor T-cell lymphoblastic leukemia/lymphoma based on radiologic and immunophenotypic findings.

Authors:  Yasushi Onishi; Yoshihiro Matsuno; Ukihide Tateishi; Akiko Miyagi Maeshima; Masahiko Kusumoto; Takashi Terauchi; Shigeru Kusumoto; Naohiro Sekiguchi; Kazuki Tanimoto; Takashi Watanabe; Yukio Kobayashi; Kensei Tobinai
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

6.  Childhood B cell lymphomas arising in the mediastinum.

Authors:  T F Carr; L Lockwood; R F Stevens; P H Morris-Jones; I Lewis; P E DaCosta; A M Kelsey
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

Review 7.  Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia.

Authors:  D M Knowles
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

8.  Correlation between immunophenotypic diversity and clinical features in B-cell lymphoblastic lymphoma.

Authors:  K Shibata; Y Shimamoto; H Yamada; M Miyahara; N Fukushima; H Yano
Journal:  Ann Hematol       Date:  1995-12       Impact factor: 3.673

9.  Phenotypic expression of T lymphocytes in thymus and peripheral lymphoid tissues.

Authors:  S M Hsu; E S Jaffe
Journal:  Am J Pathol       Date:  1985-10       Impact factor: 4.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.